CAR T-Cell Therapy Market - Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global market for CAR T-cell therapy. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the CAR T-cell therapy market structure. The market study presents exclusive information about how the CAR T-cell therapy market will grow during the forecast period 2019 - 2026.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR's study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the CAR T-cell therapy market during the forecast period.
The study is relevant for stakeholders in the CAR T-cell therapy market, including CAR T-cell therapy products manufactures, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the CAR T-cell therapy market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR's study.
The study also includes statistics as well as facts related to macroeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the CAR T-cell therapy market. Furthermore, small businesses and new entrants in the CAR T-cell therapy market too can make use of the information presented in this study, based on, which they can make appropriate business decisions to gain momentum in the CAR T-cell therapy market.
Key Questions Answered in PMR's CAR T-Cell Therapy Market Report
- Which regions will continue to remain the most profitable regional markets for CAR T-cell therapy market players?
- Which factors will essentially induce a change in the demand for CAR T-cell therapy in the forecast period?
- How will changing trends impact the CAR T-cell therapy market?
- What are key manufacturers' strategy to enhance their product adoption and improve regional product footprints?
- Which companies are leading the CAR T-cell therapy market?
- What are the winning strategies of stakeholders in the CAR T-cell therapy market to upscale their position in this landscape?
CAR T-Cell Therapy Market: Research Methodology
In PMR's study, a unique research methodology is utilized to conduct extensive research on the growth of the CAR T-cell therapy market, and reach conclusions on future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.
Secondary resources referred to analysts during the production of the CAR T-cell therapy market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the CAR T-cell therapy market, and makes PMR's projection on the growth prospects of the CAR T-Cell therapy market more accurate and reliable.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Key Market Trends
- 1.3. Market Share Analysis, By Taxonomy
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Key Success Factors
- 3.1. Iceberg Analysis
- 3.2. Revenue Opportunity Analysis
- 3.3. Parent Market Analysis
- 3.4. Pipeline Assessment
- 3.5. Potential Population Eligible for CAR T-cell Therapy, By Region
- 3.6. List of Authorized Treatment Centers in the U.S. & U.K.
- 3.7. Key Inclusion & Exclusion
4. Global CAR T-Cell Therapy Market Demand (in Value or Size in US$ Mn) Analysis 2017-2018 and Forecast, 2019-2026
- 4.1. Historical Market Value (US$ Mn) Analysis, 2017-2018
- 4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2026
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis
5. Market Background
- 5.1. Macro-Economic Factors
- 5.1.1. Increase in Healthcare Spending
- 5.1.2. Emergence of Academia as the Primary Organization for Carrying Out Research
- 5.1.3. Collaborative Efforts and Initiatives to Identify Therapies for Difficult-To-Treat Illnesses
- 5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Increasing Availability of CAR T-cell Therapy
- 5.2.2. Increasing Adoption of CAR T-cell Therapy
- 5.2.3. Superior Product Efficacy
- 5.2.4. Improving Reimbursement Scenario
- 5.2.5. Collaboration among Pharmaceutical and Biopharmaceutical Companies
- 5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis
6. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Product Type
- 6.1. Introduction / Key Findings
- 6.2. Historical Market Size (US$ Mn) and Analysis By Product Type, 2017-2018
- 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019-2026
- 6.3.1. Yescarta (axicabtagene ciloleucel)
- 6.3.2. Kymriah (tisagenlecleucel)
- 6.3.3. JCAR017 (lisocabtagene maraleucel)
- 6.3.4. bb2121 Market Attractiveness Analysis By Product Type
7. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Indication
- 7.1. Introduction / Key Findings
- 7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017-2018
- 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019-2026
- 7.3.1. Relapsed Large B-cell Lymphoma
- 7.3.2. Acute Lymphoblastic Leukemia (ALL)
- 7.3.3. Multiple Myeloma
- 7.4. Market Attractiveness Analysis By Indication
8. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by End User
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2018
- 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019-2026
- 8.3.1. Hospitals
- 8.3.2. Cancer Treatment Centers
- 8.4. Market Attractiveness Analysis By End User
9. Global CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026, by Region
- 9.1. Introduction
- 9.2. Historical Market Size (US$ Mn Analysis By Region, 2017-2018
- 9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2026
- 9.3.1. North America
- 9.3.2. Europe
- 9.3.3. Japan
- 9.4. Market Attractiveness Analysis By Region
10. North America CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
- 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
- 10.3.1. By Country
- 10.3.1.1. U.S.
- 10.3.1.2. Canada
- 10.3.2. By Product Type
- 10.3.3. By Indication
- 10.3.4. By End User
- 10.4. Market Attractiveness Analysis
- 10.5. Key Market Participants - Intensity Mapping
- 10.6. Drivers and Restraints - Impact Analysis
11. Europe CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026
- 11.1. Introduction
- 11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
- 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
- 11.3.1. By Country
- 11.3.1.1. Germany
- 11.3.1.2. Italy
- 11.3.1.3. France
- 11.3.1.4. U.K.
- 11.3.1.5. Spain
- 11.3.1.6. Rest of Europe
- 11.3.2. By Product Type
- 11.3.3. By Indication
- 11.3.4. By End User
- 11.4. Market Attractiveness Analysis
- 11.5. Key Market Participants - Intensity Mapping
- 11.6. Drivers and Restraints - Impact Analysis
12. Japan CAR T-Cell Therapy Market Analysis 2017-2018 and Forecast 2019-2026
- 12.1. Introduction
- 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2018
- 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2026
- 12.3.1. By Product Type
- 12.3.2. By Indication
- 12.3.3. By End User
- 12.4. Market Attractiveness Analysis
- 12.5. Key Market Participants - Intensity Mapping
- 12.6. Drivers and Restraints - Impact Analysis
13. Market Structure Analysis
- 13.1. Market Analysis by Tier of Companies (CAR T-Cell Therapy)
- 13.2. Market Share Analysis of Top Players
- 13.3. Market Presence Analysis
- 13.3.1. By Regional footprint of Players
- 13.3.2. Treatment foot print by Players
- 13.3.3. Channel Foot Print by Players
14. Competition Analysis
- 14.1. Competition Dashboard
- 14.2. Pricing Analysis by Competition
- 14.3. Competition Benchmarking
- 14.4. Competition Deep Dive
- 14.4.1. Novartis AG
- 14.4.1.1. Overview
- 14.4.1.2. Drug Portfolio
- 14.4.1.3. Profitability by Market Segments (Drug/Channel/Region)
- 14.4.1.4. Sales Footprint
- 14.4.1.5. Strategy Overview
- 14.4.1.5.1. Marketing Strategy
- 14.4.1.5.2. Drug Strategy
- 14.4.1.5.3. Channel Strategy
- 14.4.2. Gilead Sciences Inc.
- 14.4.2.1. Overview
- 14.4.2.2. Drug Portfolio
- 14.4.2.3. Profitability by Market Segments (Drug/Channel/Region)
- 14.4.2.4. Sales Footprint
- 14.4.2.5. Strategy Overview
- 14.4.2.5.1. Marketing Strategy
- 14.4.2.5.2. Drug Strategy
- 14.4.2.5.3. Channel Strategy
- 14.4.3. Celgene Corporation
- 14.4.3.1. Overview
- 14.4.3.2. Drug Portfolio
- 14.4.3.3. Profitability by Market Segments (Drug/Channel/Region)
- 14.4.3.4. Sales Footprint
- 14.4.3.5. Strategy Overview
- 14.4.3.5.1. Marketing Strategy
- 14.4.3.5.2. Drug Strategy
- 14.4.3.5.3. Channel Strategy
- 14.4.4. bluebird bio, Inc.
- 14.4.4.1. Overview
- 14.4.4.2. Drug Portfolio
- 14.4.4.3. Profitability by Market Segments (Drug/Channel/Region)
- 14.4.4.4. Sales Footprint
- 14.4.4.5. Strategy Overview
- 14.4.4.5.1. Marketing Strategy
- 14.4.4.5.2. Drug Strategy
- 14.4.4.5.3. Channel Strategy
15. Assumptions and Acronyms Used
16. Research Methodology
比較リスト
